Allulose for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Allulose for Health & Longevity

Created on 10/04/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Allulose, a rare sugar sold as a food ingredient, tastes and cooks much like table sugar but passes through the body almost unused, making it a substitute for added sugar. Added to a carbohydrate meal, it modestly softens the rise in blood sugar and insulin. Fat loss and other benefits remain unconfirmed. Large single servings cause diarrhea and bloating, and controlled human data cover only about three months. (Full Review)

Protocol

Sugar-replacement approach
About 1.4 g per 1 g of sugar
Replaces table sugar in drinks and baking within tolerance; 70% of sugar's sweetness
Pre-meal glucose-blunting approach
5 g with each of three meals
15 g/day; with or up to 30 minutes before carbohydrate-containing meals
Upper bound
0.4 g/kg/day
Proposed provisional safe intake for Chinese adults; tolerance limit 0.9 g/kg/day
Time to effect
Post-meal glucose
Same meal
Effects are meal-bound; each meal dose acts only on that meal
Body composition
12 weeks
Effects, if real, appeared only after 12 weeks

Benefits

Contraindications
  • People with diagnosed fructose malabsorption or irritable bowel syndrome with diarrhea (theoretical)
  • People whose intake would exceed 0.4 g/kg body weight per dose or 0.9 g/kg per day
  • Pregnant or breastfeeding women (caution; no human data)
  • People with advanced chronic kidney disease (caution, theoretical)
    •
Key Interactions
  • Insulin and sulfonylureas (oral drugs that stimulate insulin release: glimepiride, glipizide, gliclazide): Monitor (theoretical); additive glucose lowering
  • GLP-1 receptor agonists (injectable drugs mimicking GLP-1: semaglutide, tirzepatide, liraglutide): Caution (theoretical); additive nausea and diarrhea
  • Alpha-glucosidase inhibitors (drugs slowing starch digestion: acarbose, miglitol), and metformin: Caution (theoretical); additive bloating, gas and diarrhea
  • Over-the-counter osmotic laxatives (laxatives drawing water into the bowel: polyethylene glycol, magnesium citrate, lactulose): Caution (theoretical); additive loose stools and fluid loss
  • Sugar alcohols and fermentable fibers (erythritol, xylitol, sorbitol, inulin): Caution (theoretical); additive gastrointestinal load
  • Glucose-lowering supplements (berberine, chromium, cinnamon extract): Monitor (theoretical); additive effect on blood glucose
  • Fructose-rich foods: Monitor (theoretical); large combined loads may worsen malabsorption symptoms
    •

Risk & Side Effects

  • High: Dose-Dependent Gastrointestinal Symptoms
    •
  • Medium:
  • Low: Lower Protective Cholesterol and Higher Inflammatory Signaling; Reduced Bone Density Score
    •
  • Speculative: Liver and Kidney Enlargement; Fuel for Opportunistic Gut Bacteria; Root-Surface Tooth Decay
    •

Monitoring

Marker Target Why
Post-meal glucose (continuous glucose monitor or finger-stick) No established target; track the peak and rise on matched meals with versus without allulose Expected to change
HDL cholesterol ≥40 mg/dL men, ≥50 mg/dL women; also track change from own baseline Safety check
Body fat and bone density (DXA, dual-energy X-ray scan) No established target; track change from own baseline Expected to change (fat); safety check (bone)

Cadence: Baseline before regular use; repeat post-meal glucose comparisons in weeks 1–2, a lipid panel at 12 weeks, then lipids and scans every 6–12 months with continued daily use

Qualitative Assessment

  • Stool frequency and consistency, bloating and abdominal discomfort after allulose-containing meals
  • Hunger and fullness between meals
  • Energy steadiness after carbohydrate meals
  • Cravings for sweet foods
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.